Update On SOURCE Phase 3 Trial For Tezepelumab In Patients With Severe, Oral Corticosteroid-Dependent Asthma Biotech Investing
Gilead Sciences to Present at the 39th Annual J.P. Morgan Healthcare Conference on Monday, January 11, 2021 Biotech Investing
Pfizer and BioNTech Receive Authorization in the European Union for COVID-19 Vaccine Pharmaceutical Investing
Pfizer and BioNTech Receive CHMP Positive Opinion for their COVID-19 Vaccine Pharmaceutical Investing
Solarvest Launches World's First Organic DHA Omega-3 Fruit Gummy Drops for Children Biotech Investing
Algernon CEO and CSO to Discuss COVID-19 Study Interim Data Results Featured on Streetsmart Live! Webcast Biotech Investing
Metamaterial Joins The 50 - 30 Challenge Community as an Early Adopter Companies That Embrace Diversity are Twice as Likely to Outperform Their Peers Cleantech Investing
Marvel Biosciences Advances MB-204 Toward First-in Human Testing, Selects CMAX as Phase I Clinical Trial Site
